These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 8574507

  • 1. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W, Harnisch L, Zimmer M, Rokitta C, Mendes P.
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE, Hajdú P, Malerczyk V, de Looze S, Seeger K, Grötsch H.
    Clin Ther; 1987 Oct; 10(1):18-31. PubMed ID: 3450392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B, Azanza JR, Quetglas EG, Campanero MA, Honorato J, Coronel P, Gimeno M.
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
    Orsini JA, Moate PJ, Engiles J, Norman T, Poppenga R, Benson CE, Boston RC.
    J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
    [Abstract] [Full Text] [Related]

  • 10. Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion.
    Bertels RA, Semmekrot BA, Gerrits GP, Mouton JW.
    Infection; 2008 Oct; 36(5):415-20. PubMed ID: 18791659
    [Abstract] [Full Text] [Related]

  • 11. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE, Golden JA, Kelley MG, Zurlinden E.
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF, Bulitta J, Lipman J, Kirkpatrick CM.
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [Abstract] [Full Text] [Related]

  • 13. Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics.
    Nix DE, Schentag JJ.
    Diagn Microbiol Infect Dis; 1995 Nov; 22(1-2):71-6. PubMed ID: 7587053
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I, Nawishy S, Sabbour M.
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB, Pechinot A, Safran C, Chretien P, Sandre D, Kazmierczak A.
    Dev Pharmacol Ther; 1990 Feb; 14(1):29-34. PubMed ID: 2311478
    [Abstract] [Full Text] [Related]

  • 20. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.